Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort.

Cumming SA, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F, Littleford R, Gorman G, Bassez G, Schoser B, Lochmüller H, van Engelen BGM, Monckton DG; OPTIMISTIC Consortium.

Neurology. 2019 Sep 3;93(10):e995-e1009. doi: 10.1212/WNL.0000000000008056. Epub 2019 Aug 8.

PMID:
31395669
2.

Lower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI.

Heskamp L, van Nimwegen M, Ploegmakers MJ, Bassez G, Deux JF, Cumming SA, Monckton DG, van Engelen BGM, Heerschap A.

Neurology. 2019 Jun 11;92(24):e2803-e2814. doi: 10.1212/WNL.0000000000007648. Epub 2019 May 22.

3.

De novo repeat interruptions are associated with reduced somatic instability and mild or absent clinical features in myotonic dystrophy type 1.

Cumming SA, Hamilton MJ, Robb Y, Gregory H, McWilliam C, Cooper A, Adam B, McGhie J, Hamilton G, Herzyk P, Tschannen MR, Worthey E, Petty R, Ballantyne B; Scottish Myotonic Dystrophy Consortium, Warner J, Farrugia ME, Longman C, Monckton DG.

Eur J Hum Genet. 2018 Nov;26(11):1635-1647. doi: 10.1038/s41431-018-0156-9. Epub 2018 Jul 2.

4.

CRISPR/Cas9-Induced (CTG⋅CAG)n Repeat Instability in the Myotonic Dystrophy Type 1 Locus: Implications for Therapeutic Genome Editing.

van Agtmaal EL, André LM, Willemse M, Cumming SA, van Kessel IDG, van den Broek WJAA, Gourdon G, Furling D, Mouly V, Monckton DG, Wansink DG, Wieringa B.

Mol Ther. 2017 Jan 4;25(1):24-43. doi: 10.1016/j.ymthe.2016.10.014. Epub 2017 Jan 4.

5.

On-chip immunoprecipitation for protein purification.

Sandison ME, Cumming SA, Kolch W, Pitt AR.

Lab Chip. 2010 Oct 21;10(20):2805-13. doi: 10.1039/c005295g. Epub 2010 Aug 17.

PMID:
20714512
6.

A simple, sensitive and selective quantum-dot-based western blot method for the simultaneous detection of multiple targets from cell lysates.

Gilroy KL, Cumming SA, Pitt AR.

Anal Bioanal Chem. 2010 Sep;398(1):547-54. doi: 10.1007/s00216-010-3908-0. Epub 2010 Jun 27.

PMID:
20582696
7.

Characterization of a heat resistant beta-glucosidase as a new reporter in cells and mice.

McCutcheon SC, Jones K, Cumming SA, Kemp R, Ireland-Zecchini H, Saunders JC, Houghton CA, Howard LA, Winton DJ.

BMC Biol. 2010 Jun 22;8:89. doi: 10.1186/1741-7007-8-89.

8.

The RNA stability regulator HuR regulates L1 protein expression in vivo in differentiating cervical epithelial cells.

Cumming SA, Chuen-Im T, Zhang J, Graham SV.

Virology. 2009 Jan 5;383(1):142-9. doi: 10.1016/j.virol.2008.10.003. Epub 2008 Nov 4.

9.

Human papillomavirus type 16 late gene expression is regulated by cellular RNA processing factors in response to epithelial differentiation.

Cumming SA, Cheun-Im T, Milligan SG, Graham SV.

Biochem Soc Trans. 2008 Jun;36(Pt 3):522-4. doi: 10.1042/BST0360522. Review.

10.

Analysis of regulatory motifs within HPV transcripts.

Cumming SA, Graham SV.

Methods Mol Med. 2005;119:291-315.

PMID:
16350408
11.

SF2/ASF binds the human papillomavirus type 16 late RNA control element and is regulated during differentiation of virus-infected epithelial cells.

McPhillips MG, Veerapraditsin T, Cumming SA, Karali D, Milligan SG, Boner W, Morgan IM, Graham SV.

J Virol. 2004 Oct;78(19):10598-605.

12.
13.
14.
15.

Hypersensitive mousetraps, alpha1-antitrypsin deficiency and dementia.

Lomas DA, Lourbakos A, Cumming SA, Belorgey D.

Biochem Soc Trans. 2002 Apr;30(2):89-92. Review.

PMID:
12023831
16.

The human papillomavirus type 31 late 3' untranslated region contains a complex bipartite negative regulatory element.

Cumming SA, Repellin CE, McPhillips M, Radford JC, Clements JB, Graham SV.

J Virol. 2002 Jun;76(12):5993-6003.

17.

C-type natriuretic peptide expression in olfactory regions of rat brain is modulated by acute water deprivation, salt loading and central angiotensin II.

Cameron VA, Cumming SA, Espiner EA, Nicholls G, Richards M.

Neuroendocrinology. 2001 Jan;73(1):46-53.

PMID:
11174016
18.

Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion.

Portella G, Cumming SA, Liddell J, Cui W, Ireland H, Akhurst RJ, Balmain A.

Cell Growth Differ. 1998 May;9(5):393-404.

19.

Antibodies to gp41 and nef in otherwise HIV-negative homosexual man with Kaposi's sarcoma.

Bowden FJ, McPhee DA, Deacon NJ, Cumming SA, Doherty RR, Sonza S, Lucas CR, Crowe SM.

Lancet. 1991 Jun 1;337(8753):1313-4.

PMID:
1674298
20.

Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies.

Cumming SA, McPhee DA, Maskill WJ, Kemp BE, Doherty RR, Gust ID.

AIDS. 1990 Jan;4(1):83-6.

PMID:
1690552
21.

Clinical evaluation of a technetium-99m bone imaging agent based on the vicinal diphosphonate 1,2-diphosphonoethyleneglycol (DPEG).

Pauwels EK, Camps JA, Blom J, Hermans J, Kelly JD, Cumming SA, Blackburn GM, Rashid A.

Nucl Med Commun. 1985 Nov;6(11):739-45.

PMID:
3831848
22.

Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.

Nowotnik DP, Canning LR, Cumming SA, Harrison RC, Higley B, Nechvatal G, Pickett RD, Piper IM, Bayne VJ, Forster AM, et al.

Nucl Med Commun. 1985 Sep;6(9):499-506.

PMID:
3877892
23.

Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).

Holmes RA, Chaplin SB, Royston KG, Hoffman TJ, Volkert WA, Nowotnik DP, Canning LR, Cumming SA, Harrison RC, Higley B, et al.

Nucl Med Commun. 1985 Aug;6(8):443-7.

PMID:
3877890

Supplemental Content

Loading ...
Support Center